Crime doesn’t pay trebled damages: The Tipline for 26 June 2023
PharmacyChecker.com is scrambling to keep its illegal boycott claims against Big Pharma alive, but there are questions about whether it has non-antitrust laws on its side. A federal court in Manhattan threw out its case earlier this year, finding that the price comparison tool could not seek antitrust relief because it encouraged consumers to illegally import prescription drugs. While its appeal continues on the east coast, PharmacyChecker hopes it can write a different script out west. Also in Tipline, Janet Yellen predicts a wave of bank consolidation.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10